Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

44.40
Delayed Data
As of 8:47am ET
 +0.16 / +0.36%
Today’s Change
36.71
Today|||52-Week Range
44.85
+11.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues42.1B41.5B37.9B36.5B
 
 
 
 
 
Cost of Goods Sold10.3B10.6B9.4B11.1B
 
 
 
 
 
Depreciation And Amortization2.3B2.2B2.4B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income29.5B28.7B26.0B22.9B
 
 
 
 
 
General Expenses19.3B17.5B16.9B16.2B
 
 
 
 
 
Research And Development5.5B5.4B5.2B5.2B
 
 
 
 
 
Total Operating Expenses31.8B30.3B28.8B29.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income10.3B11.2B9.1B6.7B
 
 
 
 
 
Extraordinary Credit1.2B78.3M19.8M47.3M
 
 
 
 
 
Extraordinary Charge-1.4B-3.2B-4.5B-7.2B
 
 
 
 
 
Interest Expense On Debt1.2B1.1B1.1B1.0B
 
 
 
 
 
Equity In Earnings46.2M67.3M49.4M21.4M
 
 
 
 
 
Other Expenses1.6B3.3B1.2B17.4B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.6B10.3B4.8B16.0B
 
 
 
 
 
Income Taxes-3.1B-1.6B-225.6M-3.3B
 
 
 
 
 
Minority Interest-285.1M-300.7M-123.5M-76.3M
 
 
 
 
 
Net Income7.3B8.5B4.5B12.8B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.4B2.4B
 
 
 
 
 
 
Earnings Per ShareEPS$2.96$3.52$1.89$5.32
 
 
 
 
 
EPS Diluted$2.91$3.46$1.86$5.26